OtherINTERVENTIONAL
Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset
S. Sugiura, K. Iwaisako, S. Toyota and H. Takimoto
American Journal of Neuroradiology March 2008, DOI: https://doi.org/10.3174/ajnr.A1012
S. Sugiura
K. Iwaisako
S. Toyota


This is a PDF-only article. The first page of the PDF of this article appears above.
Advertisement
Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset
S. Sugiura, K. Iwaisako, S. Toyota, H. Takimoto
American Journal of Neuroradiology Mar 2008, DOI: 10.3174/ajnr.A1012
Jump to section
Related Articles
- No related articles found.
Cited By...
- Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
- Endovascular therapy yields significantly superior outcomes for large vessel occlusions compared with intravenous thrombolysis: is it time to randomize?
- Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke
- Evaluation of an Intravenous-Endovascular Strategy in Patients with Acute Proximal Middle Cerebral Artery Occlusion
- Bridging Therapy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
- The Effectiveness of Microballoon Angioplasty in Treating Middle Cerebral Artery Occlusion Beyond the Bifurcation
- Stent Placement in Acute Cerebral Artery Occlusion
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement